Immunogenicity, Safety, and Tolerability of Bivalent rLP2086 Meningococcal Group B Vaccine Administered Concomitantly With Diphtheria, Tetanus, and Acellular Pertussis and Inactivated Poliomyelitis Vaccines to Healthy Adolescents

KEY POINTS: Concomitant administration of bivalent rLP2086 (Trumenba [Pfizer, Inc] and diphtheria, tetanus, and acellular pertussis and inactivated poliovirus vaccine (DTaP/IPV) was immunologically noninferior to DTaP/IPV and saline and was safe and well tolerated. Bivalent rLP2086 elicited robust a...

Descripción completa

Detalles Bibliográficos
Autores principales: Vesikari, Timo, Wysocki, Jacek, Beeslaar, Johannes, Eiden, Joseph, Jiang, Qin, Jansen, Kathrin U., Jones, Thomas R., Harris, Shannon L., O'Neill, Robert E., York, Laura J., Perez, John L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Original Articles and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407129/
https://www.ncbi.nlm.nih.gov/pubmed/26803328
http://dx.doi.org/10.1093/jpids/piv064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407129/
https://www.ncbi.nlm.nih.gov/pubmed/26803328
http://dx.doi.org/10.1093/jpids/piv064

Ejemplares similares